Mission not yet completed: on the ups and downs of being the editor of ANP Werner Paulus Editorial 05 March 2019 Pages: 531 - 534
Translational control in brain pathologies: biological significance and therapeutic opportunities Alberto DelaidelliAsad JanPoul H. Sorensen Review 09 February 2019 Pages: 535 - 555
Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease Stephen A. SemickRahul A. BharadwajVenkata S. Mattay Original Paper 02 February 2019 Pages: 557 - 569
Tau drives translational selectivity by interacting with ribosomal proteins Shon A. KorenMatthew J. HammJose F. Abisambra Original Paper Open access 13 February 2019 Pages: 571 - 583
Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease Allison KrausEri SaijoByron Caughey Original Paper Open access 20 December 2018 Pages: 585 - 598
Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo Ilie-Cosmin StancuNiels CremersIlse Dewachter Original Paper Open access 05 February 2019 Pages: 599 - 617
Microglial nodules provide the environment for pathogenic T cells in human encephalitis Anna R. TröscherIsabella WimmerJan Bauer Original Paper Open access 20 January 2019 Pages: 619 - 635
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo André B. SilveiraLawryn H. KasperSuzanne J. Baker Original Paper 15 February 2019 Pages: 637 - 655
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma Malte HellwigMarlen C. LaufferUlrich Schüller Original Paper 04 March 2019 Pages: 657 - 673
SHH medulloblastoma in a young adult with a TCF4 germline pathogenic variation Maud BlanluetJulien Masliah-PlanchonFranck Bourdeaut Correspondence 08 March 2019 Pages: 675 - 678
Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear Rob VogelsNicolas MacagnoUta Flucke Correspondence 02 February 2019 Pages: 679 - 682
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation David W. EllisonCynthia HawkinsDavid N. Louis Correspondence 08 March 2019 Pages: 683 - 687